Magnetic Resonance Spectroscopy in Clinical Oncology

@article{Golder2004MagneticRS,
  title={Magnetic Resonance Spectroscopy in Clinical Oncology},
  author={W. Golder},
  journal={Oncology Research and Treatment},
  year={2004},
  volume={27},
  pages={304 - 309}
}
  • W. Golder
  • Published 2004
  • Medicine
  • Oncology Research and Treatment
The combination of magnetic resonance spectroscopy (MRS) and imaging (MRI) has led to mapping metabolites from normal and neoplastic tissue within the time limits of a routine study. MRSI (magnetic resonance spectroscopy imaging) detects metabolites that contain protons, phosphorus, fluorine, or other nuclei. The uniqueness of the information available in vivo and in a non-invasive manner encouraged radiologists and oncologists to apply MRSI in research and clinical practice. Both 1H- and 31P… Expand
In vivo magnetic resonance spectroscopy in cancer.
Metabolic brain imaging by magnetic resonance
Metabolic profiling of human brain metastases using in vivo proton MR spectroscopy at 3T
Clinical 1h magnetic resonance spectroscopy of brain metastases at 1.5T and 3T
Imaging of brain tumors: MR spectroscopy and metabolic imaging.
Evaluating pH in the Extracellular Tumor Microenvironment Using CEST MRI and Other Imaging Methods.
Utilization of advanced imaging technologies for target delineation in radiation oncology.
...
1
2
3
...

References

SHOWING 1-10 OF 46 REFERENCES
Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors.
  • K. Warren, J. Frank, +6 authors F. Balis
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2000
Tumor metabolism: the lessons of magnetic resonance spectroscopy.
MR spectroscopy of musculoskeletal soft-tissue tumors.
  • W. Negendank
  • Medicine
  • Magnetic resonance imaging clinics of North America
  • 1995
...
1
2
3
4
5
...